ChitogenX Inc.
CHGX
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 153.10K | 132.20K | -25.80K | 331.10K | 208.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 276.80K | 157.70K | -3.70K | 545.90K | 262.90K |
| Operating Income | -276.80K | -157.70K | 3.70K | -545.90K | -262.90K |
| Income Before Tax | -443.80K | -243.20K | -115.70K | -339.20K | -577.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -443.80K | -243.20K | -115.70K | -339.20K | -577.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -443.80K | -243.20K | -115.70K | -339.20K | -577.30K |
| EBIT | -276.80K | -157.70K | 3.70K | -545.90K | -262.90K |
| EBITDA | -270.30K | -151.20K | 10.30K | -538.50K | -254.80K |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 83.13M | 83.13M | 83.13M | 83.04M | 80.32M |
| Average Diluted Shares Outstanding | 83.13M | 83.13M | 83.13M | 83.04M | 80.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
